Endoscopic papillary balloon dilation (EPBD) is an alternative to endoscopic sphincterotomy for choledocholithiasis. Unlike endoscopic sphincterotomy, EPBD preserves biliary sphincter function, reducing long-term risk of recurrent choledocholithiasis by 50%. Guidelines recommend that duration of EPBD exceeds 2 minutes, to adequately loosen the sphincter and reduce risks of failed stone extraction and post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. However, it is unclear whether this long duration of EPBD impairs sphincter function and negates the long-term benefit of EPBD. We performed a randomized controlled trial to determine whether long-duration (>1 minute) EPBD increases the risk of subsequent choledocholithiasis and hepatobiliary complications compared with short-duration EPBD (<1 minute).
See editorial on page 1671. E ndoscopic retrograde cholangiopancreatography (ERCP) and endoscopic sphincterotomy (EST) is the standard treatment for choledocholithiasis. The addition of endoscopic papillary large balloon dilation (EPLBD) with a 12-to 20-mm balloon after EST facilitates removal of large (>15 mm) or difficult stones. For stones 10 mm, which constitute most ERCPs for stone extraction, an alternative to EST is endoscopic papillary balloon dilation (EPBD) of the biliary sphincter with a 6-to 10-mm balloon. Although the overall success rates of stone extraction are comparable, EPBD has several advantages over EST, including a lower risk of post-ERCP bleeding 1, 2 and technical ease in cases with altered/difficult anatomy. 3, 4 Furthermore, EST ablates the sphincter of Oddi and thus causes permanent loss of sphincter function; the resultant duodenobiliary reflux and bacterial colonization of bile duct predispose to subsequent stone recurrence and cholangitis. [5] [6] [7] [8] By contrast, EPBD only loosens the sphincter of Oddi and preserves sphincter function. 6, 8, 9 A meta-analysis of randomized controlled trials (RCTs) showed that EPBD reduces stone recurrence and long-term complications by about 50% compared with EST (pooled odds ratio, 0.53; 95% confidence interval [CI] , 0.36-0.77 and 0.48; 95% CI, 0.26-0.90, respectively). 10 Given potential advantages over EST in reducing short-and long-term complications, the recent European Society of Gastrointestinal Endoscopy guideline suggests EPBD as an alternative to EST for removing bile duct stones, especially in patients with coagulopathy or altered anatomy. 11 Although a short dilation duration ( 1 minute) was previously advocated, 2, 12 a study that performed EPBD for 1 minute observed a 15.4% risk of post-ERCP pancreatitis (PEP) with 2 (1.7%) cases of mortality. 13 European Society of Gastrointestinal Endoscopy guideline recommends that the duration of EPBD should exceed 2 minutes because long-duration EPBD (>1 minute) is preferred over short-duration EPBD ( 1 minute) with better short-term outcomes. 11 In an RCT, 5-minute EPBD achieved greater sphincter loosening than 1-minute EPBD, thereby significantly reducing the risk of failed stone extraction requiring rescue EST (7.1% vs 19.8%; P ¼ .024) and PEP (4.8% vs 15.1%; P ¼ .038).
14 A metaanalysis of RCTs also showed that the duration of EPBD is inversely associated with the risk of PEP. 15 However, the long-term outcome of long-duration EPBD is not clear. Previous RCTs 5, [16] [17] [18] comparing long-term outcome between EPBD and EST used short EPBD duration between 25 seconds and 1 minute, and there has been no comparison of long-term outcome between short-duration EPBD and long-duration EPBD. It is not clear if longduration EPBD permanently impairs sphincter function and predisposes to more stone recurrence and biliary complications compared with short-duration EPBD, negating the benefit of EPBD over EST.
Understanding the long-term outcomes of longduration EPBD versus short-duration EPBD is crucial in determining the optimal dilation duration and deciding between EPBD and EST for treatment of choledocholithiasis. We prospectively compared the long-term outcomes of patients who were randomized to 1-minute or 5-minute EPBD for choledocholithiasis in an RCT, and analyzed the associated risk factors for recurrent choledocholithiasis and hepatobiliary complications after EPBD.
Methods

Patients and Procedures
This study assessed the long-term outcomes (ie, beyond the first month post-ERCP) of patients who were enrolled in our previous RCT 14 comparing 1-minute versus 5-minute EPBD for removal of common bile duct stones. In this RCT, consecutive patients aged 18 years or older who underwent ERCP for suspected choledocholithiasis between April 2007 and October 2008 in 2 centers in Taiwan were invited to participate. Exclusion criteria included no stone on cholangiography, prior EST, biliary strictures or ampullary/pancreatic/ biliary malignancies, active acute pancreatitis, choledochal cyst, prior biliary surgery except cholecystectomy, pregnancy, precut sphincterotomy for biliary access, and inability to give informed consent. A total of 170 patients were randomized to 1-minute (n ¼ 86) or 5-minute (n ¼ 84) EPBD. EPBD was performed by inflating a 10-mm dilation balloon positioned at the papilla over a guidewire with diluted contrast. The size of the largest stone was 10 mm in 137 (80.6%) patients. After full balloon expansion was confirmed under fluoroscopy, the balloon was kept inflated for 1 or 5 minutes according to the randomization. Stone extraction with EPBD alone was considered a failure if the stone could not be removed with a stone extraction balloon after 2 attempts, and EST was subsequently performed as a rescue procedure. If stone clearance still failed after EST, mechanical lithotripsy was used. A comparison of the efficacy of stone extraction and early (ie, within 1 month) post-ERCP complications between the 2 EPBD durations were published previously. 14 
Data Collection and Long-Term Follow-Up
After complete common bile duct stone clearance, all patients were followed regularly in outpatient clinic and monitored for long-term complications until June 2015. One month after the initial ERCP, patients were interviewed and underwent blood sampling for liver function tests and an abdominal sonography. After that, patients were followed in outpatient clinic every 3-6 months. Further blood tests and abdominal sonography were repeated if clinically indicated. The patients were also instructed to visit the emergency department or notify their physician if they developed symptoms of biliary complications including fever, pain, and jaundice between outpatient visits. If the patient missed the scheduled outpatient appointment, the physician would telephone the patient or his or her family to inquire about emergency department visits or hospitalizations for hepatobiliary conditions, the patient's vital status, and the cause of death in deceased patients. This study was approved by the institutional review board of each medical center. All authors had access to the study data and reviewed and approved the final manuscript.
Outcomes for Assessment
The primary outcome was recurrent choledocholithiasis or acute cholangitis either with or without bile duct stones, and the secondary outcome was overall hepatobiliary complications, a composite of recurrent choledocholithiasis, acute cholangitis, cholecystitis, liver abscess, biliary malignancy, and death related to biliary diseases. The date of the occurrence of outcomes was defined as the date of diagnosis by imaging studies or emergency room visit/hospitalization for the complications, whichever came first. Patients without any hepatobiliary complication were censored at the date of last follow-up or death.
Statistical Analysis
Analysis was based on intention-to-treat. The baseline characteristics between the 2 randomized groups were compared by Fisher exact test for categorical variables and by Mann-Whitney U test for continuous variables. We compared the rates of recurrent bile duct stones or acute cholangitis and overall hepatobiliary complications between the 2 EPBD durations using Kaplan-Meier curves and log-rank test. Because rescue EST at initial ERCP might result in a loss of sphincter function and possibly a higher risk of long-term hepatobiliary complications, 5, 10 we repeated the analysis after excluding patients who underwent rescue EST in addition to EPBD as per-protocol analysis. We also compared patients who underwent EPBD alone (1-minute or 5-minute) and those who underwent rescue EST in exploratory analysis.
Cox proportional hazards regression model was used to assess the effects of EPBD duration and to identify the risk factors of long-term hepatobiliary complications after EPBD. Besides EPBD duration, potential confounders that had P < .1 in univariable analysis were entered into the multivariable regression model. The potential confounders evaluated included age, sex, bile duct diameter, rescue EST, use of mechanical lithotripsy, and periampullary diverticulum at initial ERCP, and remaining gallbladder (with or without stone) and remaining gallbladder stones during follow-up, which were treated as time-dependent covariates (ie, patients who underwent cholecystectomy during follow-up were classified as with gallbladder/gallbladder stones before the date of cholecystectomy and without gallbladder/gallbladder stones afterward). Proportional hazards assumption was checked by Schoenfeld residuals. Statistical analyses were performed using Stata version 13 (StataCorp, College Station, TX). All tests were 2-tailed, and differences were considered significant if P < .05.
In the previous study that reported long-term outcomes after short-duration EPBD, the cumulative incidence of recurrent biliary complications seemed to plateau by 7 years after EPBD. 5 Therefore, we followed the patients until 2015, a total of 7 years after the end of trial recruitment. Assuming a rate of recurrent choledocholithiasis or hepatobiliary complications of 20% after 1-minute EPBD and a significance level of 0.05, a total of 85 patients in each group would provide 80% power to detect a difference in the survival curves corresponding to a hazard ratio (HR) of 2.31 (nQuery Advisor 4.0, Statistical Solutions Ltd, Boston, MA). Figure 1 summarizes the number of patients followed and assessed for outcomes. There was no significant difference between patients randomized to 1-minute or 5-minute EPBD in baseline characteristics including the number and size of stones (Table 1) . More patients in the 1-minute EPBD group had failed stone extraction after EPBD alone requiring rescue EST at the initial ERCP ( Table 1 ). The median duration of follow-up was 7.4 years (interquartile range, 6.6-8) for the 1-minute EPBD group and 6.9 years (interquartile range, 6.7-7.7) for the 5-minute EPBD group (P ¼ .111).
Results
Patient Characteristics
Comparison Between 1-Minute and 5-Minute Endoscopic Papillary Balloon Dilation
The results of long-term follow-up are summarized in Table 2 . By intention-to-treat analysis, there was no significant difference in the rate of recurrent choledocholithiasis or acute cholangitis during follow-up between patients randomized to either 1-minute EPBD (13 of 86; 15.1%) or 5-minute EPBD (10 of 84; 11.9%; P ¼ .352) (Figure 2A ). All those patients were successfully treated with repeat ERCPs and antibiotics. The 2 groups were also comparable in the rate of overall hepatobiliary complications (P ¼ .154) (Table 2, Figure 3A) . Fourteen patients in the 1-minute EPBD group and 12 in the 5-minute EPBD group died from causes unrelated to biliary diseases (P ¼ .588). Per-protocol analysis after excluding patients who received rescue EST yielded similar results, showing no significant difference between the 2 EPBD durations in either primary or secondary outcomes ( Table 2 , Figures 2B and 3B ).
Comparison Between Endoscopic Papillary Balloon Dilation Alone and Endoscopic Papillary Balloon Dilation Plus Rescue Endoscopic Sphincterotomy
Among 152 patients who underwent EPBD alone (1-minute or 5-minute), recurrent choledocholithiasis or acute cholangitis and overall hepatobiliary complications occurred in 17 (11.2%) and 23 (15.1%), respectively. In comparison, patients who underwent rescue EST following EPBD (n ¼ 18) had a higher rate of recurrent choledocholithiasis or acute cholangitis (6; 33.3%; P ¼ .022) and overall hepatobiliary complications (7; 38.9%; P ¼ .031) (Supplementary Figure 1) .
Risk Factors of Long-Term Complications
The results of Cox regression analyses are summarized in Table 3 . Compared with 1-minute EPBD, 5-minute EPBD was not associated with an increased rate of recurrent choledocholithiasis or acute cholangitis and overall hepatobiliary complications (adjusted HR [aHR], 0.76; 95% CI, 0.32-1.82; P ¼ .541 and aHR, 0.65; 95% CI, 0.31-1.40; P ¼ .271, respectively). Notably, mechanical lithotripsy at initial ERCP was associated with a significant increase in primary and secondary outcomes (aHR, 4.55; 95% CI, 1.49-13.84; P ¼ .008 and 3.54; 95% CI, 1.24-10.13; P ¼ .018, respectively). Greater common bile duct diameter at initial ERCP was also associated with a modest increase in the rate of both outcomes.
Discussion
This is the first study to assess how the dilation duration impacts the long-term outcomes after EPBD for bile duct stones. We found that EPBD for 5 minutes did not result in a higher long-term risk of stone recurrence and hepatobiliary complications compared with EPBD for 1 minute. We also noted that mechanical lithotripsy, performed when stone extraction with EPBD failed, increased the risk of subsequent stone recurrence and hepatobiliary complications.
The duration of dilation critically affects the shortterm outcomes of EPBD. Previous RCT and metaanalysis have shown that inadequate sphincter loosening after short-duration EPBD increases the risk of failed stone extraction by EPBD and limits volume expansion of the contents encircled within the sphincter, worsening compression of the pancreatic orifice from post-EPBD edema and thus increasing the risk of PEP (compartment syndrome theory).
14,15 A meta-analysis of 12 RCTs showed that every 1-minute increase in the duration of dilation up to 3 minutes was associated with a 49.8% reduction in the odds ratio for PEP. 15 Notably, the US RCT that was prematurely stopped because of 2 deaths from pancreatitis after EPBD used 1-minute EPBD, 13 and the risk of PEP in that study (15.4%) was similar with that of the 1-minute EPBD group in this study (15.1%). By contrast, the risk of PEP with 5-minute EPBD in this study was only 4.8% (P ¼ .038). This study further demonstrates that long-duration EPBD is similar to short-duration EPBD in terms of long-term safety and underscores the importance of dilation for an adequate duration to maximize the chance of ductal clearance by EPBD alone, avoiding the need for rescue EST or mechanical lithotripsy and the associated late complications. These results support dilation duration of 5 minutes to achieve the best short-and long-term outcomes for EPBD.
We noted that the rate of stone recurrence or cholangitis was higher after rescue EST compared with EPBD alone (33.3% vs 11.2%; P ¼ .022), but the HR of stone recurrence for rescue EST became statistically nonsignificant after adjustment for confounders. These results were from exploratory analysis and should be interpreted with caution. This study was not designed to compare EST and EPBD. Because only 10.6% of patients underwent rescue EST, the statistical power may be inadequate.
Recent evidence calls for a reappraisal of the first-line treatment for choledocholithiasis. Given potential benefits of better short-and long-term safety, EPBD can be used as the first-line treatment for stones 10 mm, particularly in patients at increased risk of bleeding, with EST being considered as the second-line rescue treatment. Compared with EST, RCTs and meta-analyses have consistently shown that EPBD has comparable overall success rate of stone extraction, 1,2 but eliminates the 2% risk of bleeding after EST and nearly halves the The number of patients with gallbladder stones at initial ERCP as denominator.
long-term stone recurrence and biliary complications. 1, 2, 10 Despite these advantages, the use of EPBD remains limited because of previous studies showing a higher risk of PEP. 2, 13 However, subsequent RCT and meta-analysis have shown that the risk of PEP is inversely related to the dilation duration of EPBD. Although short-duration EPBD significantly increases the risk of PEP, long-duration EPBD does not pose a higher PEP risk compared with EST; EPBD >1 minute has a lower rate of overall post-ERCP complications compared with EST because of a comparable PEP risk but minimal risk of bleeding. 14, 15 EST is a common procedure; approximately 150,000 ESTs are performed annually in the United States. 19 Use of EPBD instead of EST as the first-line treatment for bile duct stones 10 mm may lead to a significant reduction in both short-and longterm morbidity and should be evaluated by additional prospective multicenter/multinational comparative studies of adequate power.
For stones 10-15 mm, stone extraction with EPBD alone has a high failure rate, which reached 62.5% (n ¼ 16) after 1-minute EPBD and 16.7% (n ¼ 12) after 5-minute EPBD during the initial ERCP in this study. Therefore, EST or EPLBD is preferred over EPBD for stones 10-15 mm. However, EPBD may still be useful for the subgroup of patients who are at high risk of post-EST bleeding and post-EPLBD perforation because of a narrow distal bile duct; mechanical lithotripsy is often needed to achieve stone extraction.
For stones that are >15 mm or cannot be extracted after EST, EPLBD is preferred over mechanical lithotripsy, provided EPLBD is not contraindicated because of narrowing of the distal bile duct. 20 The novel finding that mechanical lithotripsy nearly quadruples the subsequent risk of stone recurrence and hepatobiliary complications further supports that a stone should be extracted in 1 piece whenever possible. A retrospective study also noted that mechanical lithotripsy was significantly associated with stone recurrence after EST (aHR, 2.34; 95% CI, 0.04-5.13; P ¼ .0342). 21 The increased risk of stone recurrence might be secondary to tiny residual stone fragments/sludge generated from stone fragmentation, which serve as a nidus for subsequent stone formation. An RCT comparing mechanical lithotripsy with EPLBD to remove large bile duct stones intact also found that whereas stone clearance was comparable, EPLBD had a lower risk of cholangitis compared with mechanical lithotripsy (0% vs 13.3%; P ¼ .026). 22 Taken together, mechanical lithotripsy should be used only when extracting the stone intact is unsuccessful or judged not to be feasible. If mechanical lithotripsy is performed, additional maneuvers to reduce residual stone fragments/sludge should be performed, such as irrigation/flushing starting from the proximal duct followed by balloon or basket sweeps, or suctioning bile with an opened basket to collapse the bile duct while withdrawing the opened basket to capture the stone fragments.
Although an RCT comparing EPBD with EST showed an association between remaining gallbladder stones and recurrent choledocholithiasis, 5 the association between remaining gallbladder (with or without stone) or remaining gallbladder stones and outcomes was not statistically significant in this study. To account for differences in follow-up duration and the interval between initial ERCP and subsequent complications among patients, we used Cox regression to assess how potential risk factors affected the rate at which complications occurred. Furthermore, we treated remaining gallbladder or stones as a time-dependent covariate, accounting for whether patients had remaining gallbladder or stones on each day during follow-up and its temporal relationship with the occurrence of complications. It should be noted that the lack of association in this study could be caused by a type II error, but our finding raises the possibility that the association between remaining gallbladder stones and recurrent choledocholithiasis may be weaker than previously reported and deserves further investigation. This is the first study to compare the long-term outcome of long-duration EPBD and short-duration EPBD. The comprehensive and extended follow-up provides novel insights into the relationship between the duration of EPBD and its long-term outcomes and the risk factors of subsequent stone recurrence and hepatobiliary complications. We analyze the rate at which recurrent stone/complications occurred with consideration of changes in the status of gallbladder stones during follow-up; therefore, our analysis should provide more precise estimates. A limitation of this study was the lack of manometry to document any difference in the post-EPBD sphincter function between the 2 EPBD durations. Nevertheless, any difference in manometric measurements does not necessarily reflect differences in clinical outcome. Therefore, we believe that a repeat ERCP simply for manometry is not justified. Secondly, we could not rule out the possibility that some cases of recurrent choledocholithiasis might be asymptomatic and evade detection by history, blood tests, and sonography during follow-up. Because it is not feasible to perform ERCP, endoscopic ultrasound, or magnetic resonance cholangiopancreatography to rule out asymptomatic choledocholithiasis in all patients without apparent recurrence at the end of follow-up, this limitation is shared by similar studies. However, given that both groups of patients were followed with the same protocol, this limitation should not cause bias in comparing between the 2 groups. Lastly, we did not ascertain the composition of stones at the initial ERCP; therefore, we could not examine whether differences in stone composition affected the risk of recurrent choledocholithiasis and hepatobiliary complications. However, the distribution of stone composition should be comparable between the 2 groups with randomization and should not cause confounding in comparing the 2 groups.
In conclusion, EPBD for 5 minutes can be safely performed without posing a higher risk of subsequent recurrent choledocholithiasis and hepatobiliary complications compared with EPBD for 1 minute. Removing stones intact without mechanical lithotripsy may reduce recurrent choledocholithiasis and hepatobiliary complications.
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